Ensuring COVID Vaccinations for All
Eighteen months after a COVID-19 vaccine became available, high-income countries had administered more than 200 doses per 100 people; in low-income countries, the figure was almost 90 percent less. Access to diagnostics and therapies has been likewise constricted, underscoring the imperative of new approaches to global health equity. Investing in local manufacturing and scientific capacity, bolstering the public health infrastructure, prioritizing community engagement, and developing alternatives to the costly mRNA vaccine are all steps forward. How do we ensure that anyone who wants to be vaccinated against COVID has that option?